- West Pharmaceutical upgraded to Buy from Neutral at UBS
UBS upgraded West Pharmaceutical (WST) to Buy from Neutral with a price
target of $390, up from $350. The firm has incremental confidence in...
from: Yahoo Finance
|
- How Is West Pharmaceutical Services' Stock Performance Compared to Other
Medical Devices Stocks?
Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs,
manufactures and sells containment and delivery systems for...
from: Nasdaq
|
- Bank of America Increases West Pharmaceutical Services (NYSE:WST) Price
Target to $355.00
Bank of America upped their price target on shares of West Pharmaceutical
Services from $350.00 to $355.00 and gave the company a "buy"...
from: MarketBeat
|
- West Pharmaceutical initiated with a Peer Perform at Wolfe Research
Wolfe Research analyst Doug Schenkel initiated coverage of West
Pharmaceutical (WST) with a Peer Perform rating and no price target West...
from: Yahoo Finance
|
- West Pharmaceutical initiated with a Peer Perform at Wolfe Research
Wolfe Research initiated coverage of West Pharmaceutical (WST) with a Peer
Perform rating. Published first on TheFly – the ultimate source for real...
from: MSN
|
- Should You Sell Your Holdings in West Pharmaceutical Services (WST)?
ClearBridge Investments, an investment management company, released its
“ClearBridge Mid Cap Growth Strategy” third quarter 2024 investor...
from: Yahoo Finance
|
- Wolfe Research Initiates Coverage of West Pharmaceutical Services (WST)
with Peer Perform Recommendation
Fintel reports that on December 13, 2024, Wolfe Research initiated coverage
of West Pharmaceutical Services (NYSE:WST) with a Peer Perform...
from: Nasdaq
|
- How Is West Pharmaceutical Services' Stock Performance Compared to Other
Medical Devices Stocks?
West Pharmaceutical Services has underperformed other medical devices
stocks over the past year, yet analysts remain bullish on the stock's...
from: Barchart.com
|
- West Pharmaceutical Services, Inc. (NYSE:WST) Given Average Rating of
"Moderate Buy" by Analysts
Shares of West Pharmaceutical Services, Inc. (NYSE:WST - Get Free Report)
have earned a consensus recommendation of "Moderate Buy" from the...
from: MarketBeat
|
